166 related articles for article (PubMed ID: 14992357)
1. Differentiation between benign and malignant hepatic lesions: utility of color stimulated acoustic emission with the microbubble contrast agent Levovist.
von Herbay A; Vogt C; Häussinger D
J Ultrasound Med; 2004 Feb; 23(2):207-15. PubMed ID: 14992357
[TBL] [Abstract][Full Text] [Related]
2. Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liver.
von Herbay A; Vogt C; Häussinger D
AJR Am J Roentgenol; 2002 Nov; 179(5):1273-9. PubMed ID: 12388513
[TBL] [Abstract][Full Text] [Related]
3. Pulse inversion sonography in the early phase of the sonographic contrast agent Levovist: differentiation between benign and malignant focal liver lesions.
von Herbay A; Vogt C; Häussinger D
J Ultrasound Med; 2002 Nov; 21(11):1191-200. PubMed ID: 12418760
[TBL] [Abstract][Full Text] [Related]
4. Value of contrast-enhanced sonography for the characterization of focal hepatic lesions in patients with diffuse liver disease: receiver operating characteristic analysis.
Kim SH; Lee JM; Lee JY; Han JK; An SK; Han CJ; Lee KH; Hwang SS; Choi BI
AJR Am J Roentgenol; 2005 Apr; 184(4):1077-84. PubMed ID: 15788576
[TBL] [Abstract][Full Text] [Related]
5. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions.
von Herbay A; Vogt C; Willers R; Häussinger D
J Ultrasound Med; 2004 Dec; 23(12):1557-68. PubMed ID: 15557299
[TBL] [Abstract][Full Text] [Related]
6. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
[TBL] [Abstract][Full Text] [Related]
7. Do different types of liver lesions differ in their uptake of the microbubble contrast agent SH U 508A in the late liver phase? Early experience.
Blomley MJ; Sidhu PS; Cosgrove DO; Albrecht T; Harvey CJ; Heckemann RA; Butler-Barnes J; Eckersley RJ; Basilico R
Radiology; 2001 Sep; 220(3):661-7. PubMed ID: 11526264
[TBL] [Abstract][Full Text] [Related]
8. Characterization of focal hepatic lesions in cirrhotic patients by Pulse Inversion Harmonic Imaging US contrast specific technique with Levovist.
Quaia E; Forgács B; Calderan L; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2002 Oct; 104(4):285-94. PubMed ID: 12569309
[TBL] [Abstract][Full Text] [Related]
9. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
10. Characterization and detection of hepatocellular carcinoma (HCC): comparison of the ultrasound contrast agents SonoVue (BR 1) and Levovist (SH U 508A)--comparison of SonoVue and Levovist in HCC.
von Herbay A; Haeussinger D; Gregor M; Vogt C
Ultraschall Med; 2007 Apr; 28(2):168-75. PubMed ID: 17447216
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients.
von Herbay A; Westendorff J; Gregor M
J Clin Ultrasound; 2010 Jan; 38(1):1-9. PubMed ID: 19790253
[TBL] [Abstract][Full Text] [Related]
12. Characterization of hyperechoic focal liver lesions: quantitative evaluation with pulse inversion harmonic imaging in the late phase of levovist.
Celik H; Ozdemir H; Yücel C; Gultekin S; Oktar SO; Arac M
J Ultrasound Med; 2005 Jan; 24(1):39-47. PubMed ID: 15615927
[TBL] [Abstract][Full Text] [Related]
13. Enhanced color flows in hepatic tumors.
Yang CC; Chen CH; Yeh YH
Hepatogastroenterology; 2002; 49(48):1506-9. PubMed ID: 12397719
[TBL] [Abstract][Full Text] [Related]
14. [Stimulated acoustic emissions with the ultrasound contrast medium levovist: a clinically useful contrast effect with liver-specific properties].
Albrecht T; Blomley MJ; Heckemann RA; Cosgrove DO; Jayaram V; Butler-Barnes J; Eckersley RJ; Hoffmann CW; Bauer A
Rofo; 2000 Jan; 172(1):61-7. PubMed ID: 10719465
[TBL] [Abstract][Full Text] [Related]
15. Echo-enhanced Doppler sonography of focal nodular hyperplasia of the liver.
Uggowitzer MM; Kugler C; Mischinger HJ; Gröll R; Ruppert-Kohlmayr A; Preidler KW; Quehenberger F
J Ultrasound Med; 1999 Jul; 18(7):445-51; quiz 453-4. PubMed ID: 10400046
[TBL] [Abstract][Full Text] [Related]
16. Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US.
Dill-Macky MJ; Burns PN; Khalili K; Wilson SR
Radiology; 2002 Jan; 222(1):95-102. PubMed ID: 11756711
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced agent detection imaging: value in the characterization of focal hepatic lesions.
Youk JH; Kim CS; Lee JM
J Ultrasound Med; 2003 Sep; 22(9):897-910. PubMed ID: 14510261
[TBL] [Abstract][Full Text] [Related]
18. [Value of combined conventional and contrast enhanced sonography in the evaluation of hepatic disorders].
Tranquart F; Bleuzen A; Kissel A
J Radiol; 2004 Jun; 85(6 Pt 1):755-62. PubMed ID: 15243376
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of benign from malignant liver masses with Acoustic Radiation Force Impulse technique.
Yu H; Wilson SR
Ultrasound Q; 2011 Dec; 27(4):217-23. PubMed ID: 22124386
[TBL] [Abstract][Full Text] [Related]
20. [Focal liver lesions: clinical usefulness of contrast-enhanced ultrasound in the selection of surgical patients].
Bartolotta TV; Sandonato L; Taibbi A; Latteri S; Soresi M; Lombardo G; Genova C; Latteri MA
Chir Ital; 2009; 61(3):295-307. PubMed ID: 19694231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]